Abstract
Α number of genetic variants have been associated with Alzheimer’s disease (AD) susceptibility. Sec1 family domain-containing protein 1 (SCFD1) gene polymorphism rs10139154 has recently been implicated in the risk of developing amyotrophic lateral sclerosis (ALS). Similarities in the pathogenetic cascade of both diseases have also been described. The present study was designed to evaluate the possible contribution of SCFD1 rs10139154 to AD. A total of 327 patients with AD and an equal number of healthy controls were included in the study and genotyped for rs10139154. With logistic regression analyses, rs10139154 was examined for the association with the risk of developing AD. In the recessive mode, SCFD1 rs10139154 was associated with a decreased risk of developing AD (odds ratio (OR) (95% confidence interval (CI)) = 0.63 (0.40–0.97), p = 0.036). The current study provides preliminary evidence of the involvement of SCFD1 rs10139154 in the risk of developing AD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
2017 Alzheimer’s disease facts and figures (2017) Alzheimer's & Dementia 13:325–373 https://doi.org/10.1016/j.jalz.2017.02.001
Alonso AD, Cohen LS, Corbo C, Morozova V, ElIdrissi A, Phillips G, Kleiman FE (2018) Hyperphosphorylation of tau associates with changes in its function beyond microtubule stability. Front Cell Neurosci 12:338. https://doi.org/10.3389/fncel.2018.00338
Anastasiou CA, Yannakoulia M, Kosmidis MH, Dardiotis E, Hadjigeorgiou GM, Sakka P, Arampatzi X, Bougea A, Labropoulos I, Scarmeas N (2017) Mediterranean diet and cognitive health: initial results from the Hellenic Longitudinal Investigation of Ageing and Diet. PLoS One 12:e0182048. https://doi.org/10.1371/journal.pone.0182048
Androutsopoulos VP, Kanavouras K, Tsatsakis AM (2011) Role of paraoxonase 1 (PON1) in organophosphate metabolism: implications in neurodegenerative diseases. Toxicol Appl Pharmacol 256:418–424. https://doi.org/10.1016/j.taap.2011.08.009
Aoki Y, Manzano R, Lee Y, Dafinca R, Aoki M, Douglas AGL, Varela MA, Sathyaprakash C, Scaber J, Barbagallo P, Vader P, Mäger I, Ezzat K, Turner MR, Ito N, Gasco S, Ohbayashi N, el Andaloussi S, Takeda S’, Fukuda M, Talbot K, Wood MJA (2017) C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia. Brain 140:887–897. https://doi.org/10.1093/brain/awx024
Argentieri MA, Nagarajan S, Seddighzadeh B, Baccarelli AA, Shields AE (2017) Epigenetic pathways in human disease: the impact of DNA methylation on stress-related pathogenesis and current challenges in biomarker development. EBioMedicine 18:327–350. https://doi.org/10.1016/j.ebiom.2017.03.044
Ashraf GM et al (2016) Recent updates on the association between Alzheimer’s disease and vascular dementia medicinal chemistry. Shariqah (United Arab Emirates) 12:226–237
Ashton NJ, Schöll M, Heurling K, Gkanatsiou E, Portelius E, Höglund K, Brinkmalm G, Hye A, Blennow K, Zetterberg H (2018) Update on biomarkers for amyloid pathology in Alzheimer’s disease. Biomark Med 12:799–812. https://doi.org/10.2217/bmm-2017-0433
Baltazar MT, Dinis-Oliveira RJ, de Lourdes Bastos M, Tsatsakis AM, Duarte JA, Carvalho F (2014) Pesticides exposure as etiological factors of Parkinson’s disease and other neurodegenerative diseases--a mechanistic approach. Toxicol Lett 230:85–103. https://doi.org/10.1016/j.toxlet.2014.01.039
Bando Y, Katayama T, Taniguchi M, Ishibashi T, Matsuo N, Ogawa S, Tohyama M (2005) RA410/Sly1 suppresses MPP+ and 6-hydroxydopamine-induced cell death in SH-SY5Y cells. Neurobiol Dis 18:143–151. https://doi.org/10.1016/j.nbd.2004.09.008
Beharry C, Cohen LS, Di J, Ibrahim K, Briffa-Mirabella S, Alonso Adel C (2014) Tau-induced neurodegeneration: mechanisms and targets. Neurosci Bull 30:346–358. https://doi.org/10.1007/s12264-013-1414-z
Bekris LM, Yu C-E, Bird TD, Tsuang DW (2010) Genetics of Alzheimer disease Journal of geriatric psychiatry and neurology 23:213–227 doi:https://doi.org/10.1177/0891988710383571
Bourdenx M, Koulakiotis NS, Sanoudou D, Bezard E, Dehay B, Tsarbopoulos A (2017) Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: examples of amyloidopathies, tauopathies and synucleinopathies. Prog Neurobiol 155:171–193. https://doi.org/10.1016/j.pneurobio.2015.07.003
Carmona S, Hardy J, Guerreiro R (2018) The genetic landscape of Alzheimer disease. Handb Clin Neurol 148:395–408. https://doi.org/10.1016/b978-0-444-64076-5.00026-0
Carr CM, Rizo J (2010) At the junction of SNARE and SM protein function. Curr Opin Cell Biol 22:488–495. https://doi.org/10.1016/j.ceb.2010.04.006
Chen Y, Zhou Q, Gu X, Wei Q, Cao B, Liu H, Hou Y, Shang H (2018) An association study between SCFD1 rs10139154 variant and amyotrophic lateral sclerosis in a Chinese cohort. Amyotroph Lateral Scler Frontotemporal Degener 19:413–418. https://doi.org/10.1080/21678421.2017.1418006
Conlon EG et al (2018) Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism. eLife 7. https://doi.org/10.7554/eLife.37754
Corder EH, Saunders A, Strittmatter W, Schmechel D, Gaskell P, Small G, Roses A, Haines J, Pericak-Vance M (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science (New York, NY) 261:921–923
Costa C, Tsatsakis A, Mamoulakis C, Teodoro M, Briguglio G, Caruso E, Tsoukalas D, Margina D, Dardiotis E, Kouretas D, Fenga C (2017) Current evidence on the effect of dietary polyphenols intake on chronic diseases. Food Chem Toxicol 110:286–299. https://doi.org/10.1016/j.fct.2017.10.023
Cubinkova V, Valachova B, Uhrinova I, Brezovakova V, Smolek T, Jadhav S, Zilka N (2018) Alternative hypotheses related to Alzheimer’s disease. Bratislavske lekarske listy 119:210–216. https://doi.org/10.4149/bll_2018_039
Cuyvers E, Sleegers K (2016) Genetic variations underlying Alzheimer’s disease: evidence from genome-wide association studies and beyond. Lancet Neurol 15:857–868. https://doi.org/10.1016/s1474-4422(16)00127-7
Danborg PB, Simonsen AH, Waldemar G, Heegaard NH (2014) The potential of microRNAs as biofluid markers of neurodegenerative diseases--a systematic review. Biomarkers 19:259–268. https://doi.org/10.3109/1354750x.2014.904001
Dardiotis E, Xiromerisiou G, Hadjichristodoulou C, Tsatsakis AM, Wilks MF, Hadjigeorgiou GM (2013) The interplay between environmental and genetic factors in Parkinson’s disease susceptibility: the evidence for pesticides. Toxicology 307:17–23. https://doi.org/10.1016/j.tox.2012.12.016
Dardiotis E, Kosmidis MH, Yannakoulia M, Hadjigeorgiou GM, Scarmeas N (2014a) The Hellenic Longitudinal Investigation of Aging and Diet (HELIAD): rationale, study design, and cohort description. Neuroepidemiology 43:9–14. https://doi.org/10.1159/000362723
Dardiotis E, Paterakis K, Tsivgoulis G, Tsintou M, Hadjigeorgiou GF, Dardioti M, Grigoriadis S, Simeonidou C, Komnos A, Kapsalaki E, Fountas K, Hadjigeorgiou GM (2014b) AQP4 tag single nucleotide polymorphisms in patients with traumatic brain injury. J Neurotrauma 31:1920–1926. https://doi.org/10.1089/neu.2014.3347
Dardiotis E, Siokas V, Zafeiridis T, Paterakis K, Tsivgoulis G, Dardioti M, Grigoriadis S, Simeonidou C, Deretzi G, Zintzaras E, Jagiella J, Hadjigeorgiou GM (2017) Integrins AV and B8 gene polymorphisms and risk for intracerebral hemorrhage in Greek and Polish populations. NeuroMolecular Med 19:69–80. https://doi.org/10.1007/s12017-016-8429-3
Dardiotis E, Siokas V, Garas A, Paraskevaidis E, Kyrgiou M, Xiromerisiou G, Deligeoroglou E, Galazios G, Kontomanolis E, Spandidos D, Tsatsakis A, Daponte A (2018a) Genetic variations in the SULF1 gene alter the risk of cervical cancer and precancerous lesions. Oncol Lett 16:3833–3841. https://doi.org/10.3892/ol.2018.9104
Dardiotis E, Siokas V, Sokratous M, Tsouris Z, Michalopoulou A, Andravizou A, Dastamani M, Ralli S, Vinceti M, Tsatsakis A, Hadjigeorgiou GM (2018b) Genetic polymorphisms in amyotrophic lateral sclerosis: evidence for implication in detoxification pathways of environmental toxicants. Environ Int 116:122–135. https://doi.org/10.1016/j.envint.2018.04.008
Dardiotis E, Karampinis E, Siokas V, Aloizou AM, Rikos D, Ralli S, Papadimitriou D, Bogdanos DP, Hadjigeorgiou GM (2019) ERCC6L2 rs591486 polymorphism and risk for amyotrophic lateral sclerosis in Greek population. Neurol Sci 40:1237–1244. https://doi.org/10.1007/s10072-019-03825-3
Dascher C, Balch WE (1996) Mammalian Sly1 regulates syntaxin 5 function in endoplasmic reticulum to Golgi transport. J Biol Chem 271:15866–15869
Friese MA, Schattling B, Fugger L (2014) Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol 10:225–238. https://doi.org/10.1038/nrneurol.2014.37
Fyfe I (2018) Epigenetics links ageing with Alzheimer disease. Nat Rev Neurol 14:254. https://doi.org/10.1038/nrneurol.2018.36
Garcia-Gonzalez P, Cabral-Miranda F, Hetz C, Osorio F (2018) Interplay between the unfolded protein response and immune function in the development of neurodegenerative diseases. Front Immunol 9:2541. https://doi.org/10.3389/fimmu.2018.02541
Gerritsen AA, Bakker C, Verhey FR, de Vugt ME, Melis RJ, Koopmans RT (2016) Prevalence of comorbidity in patients with young-onset Alzheimer disease compared with late-onset: a comparative cohort study. J Am Med Dir Assoc 17:318–323. https://doi.org/10.1016/j.jamda.2015.11.011
Goedert M (2015) NEURODEGENERATION. Alzheimer’s and Parkinson’s diseases: the prion concept in relation to assembled Abeta, tau, and alpha-synuclein. Science (New York) 349:1255555. https://doi.org/10.1126/science.1255555
Gubandru M, Margina D, Tsitsimpikou C, Goutzourelas N, Tsarouhas K, Ilie M, Tsatsakis AM, Kouretas D (2013) Alzheimer’s disease treated patients showed different patterns for oxidative stress and inflammation markers. Food Chem Toxicol 61:209–214. https://doi.org/10.1016/j.fct.2013.07.013
Haeusler AR, Donnelly CJ, Periz G, Simko EAJ, Shaw PG, Kim MS, Maragakis NJ, Troncoso JC, Pandey A, Sattler R, Rothstein JD, Wang J (2014) C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature 507:195–200. https://doi.org/10.1038/nature13124
Haines JL (2018) Alzheimer disease: perspectives from epidemiology and genetics. J Law Med Ethics 46:694–698. https://doi.org/10.1177/1073110518804230
Hardy J (2017) The discovery of Alzheimer-causing mutations in the APP gene and the formulation of the “amyloid cascade hypothesis”. FEBS J 284:1040–1044. https://doi.org/10.1111/febs.14004
Hou N, Yang Y, Scott IC, Lou X (2017) The Sec domain protein Scfd1 facilitates trafficking of ECM components during chondrogenesis. Dev Biol 421:8–15. https://doi.org/10.1016/j.ydbio.2016.11.010
Jouroukhin Y, Ostritsky R, Assaf Y, Pelled G, Giladi E, Gozes I (2013) NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: protection against impairments in axonal transport. Neurobiol Dis 56:79–94. https://doi.org/10.1016/j.nbd.2013.04.012
Jovičić A, Mertens J, Boeynaems S, Bogaert E, Chai N, Yamada SB, Paul JW, Sun S, Herdy JR, Bieri G, Kramer NJ, Gage FH, van den Bosch L, Robberecht W, Gitler AD (2015) Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat Neurosci 18:1226–1229. https://doi.org/10.1038/nn.4085
Karch CM, Goate AM (2015) Alzheimer’s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry 77:43–51. https://doi.org/10.1016/j.biopsych.2014.05.006
Katsarou MS, Papasavva M, Latsi R, Toliza I, Gkaros AP, Papakonstantinou S, Gatzonis S, Mitsikostas DD, Kovatsi L, Isotov BN, Tsatsakis AM, Drakoulis N (2018) Population-based analysis of cluster headache-associated genetic polymorphisms. J Mol Neurosci 65:367–376. https://doi.org/10.1007/s12031-018-1103-5
Korczyn AD (2008) The amyloid cascade hypothesis. Alzheimer's Dement 4:176–178. https://doi.org/10.1016/j.jalz.2007.11.008
Lipnicki DM, Crawford JD, Dutta R, Thalamuthu A, Kochan NA, Andrews G, Lima-Costa MF, Castro-Costa E, Brayne C, Matthews FE, Stephan BCM, Lipton RB, Katz MJ, Ritchie K, Scali J, Ancelin ML, Scarmeas N, Yannakoulia M, Dardiotis E, Lam LCW, Wong CHY, Fung AWT, Guaita A, Vaccaro R, Davin A, Kim KW, Han JW, Kim TH, Anstey KJ, Cherbuin N, Butterworth P, Scazufca M, Kumagai S, Chen S, Narazaki K, Ng TP, Gao Q, Reppermund S, Brodaty H, Lobo A, Lopez-Anton R, Santabárbara J, Sachdev PS, Cohort Studies of Memory in an International Consortium (COSMIC) (2017) Age-related cognitive decline and associations with sex, education and apolipoprotein E genotype across ethnocultural groups and geographic regions: a collaborative cohort study. PLoS Med 14:e1002261. https://doi.org/10.1371/journal.pmed.1002261
Liu C-C, Liu C-C, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9:106–118. https://doi.org/10.1038/nrneurol.2012.263
Luca M, Luca A, Calandra C (2015) The role of oxidative damage in the pathogenesis and progression of Alzheimer’s disease and vascular dementia. Oxidative Med Cell Longev 2015:504678. https://doi.org/10.1155/2015/504678
Lyubartseva G, Lovell MA (2012) A potential role for zinc alterations in the pathogenesis of Alzheimer’s disease. BioFactors (Oxford, England) 38:98–106. https://doi.org/10.1002/biof.199
Magalingam KB, Radhakrishnan A, Ping NS, Haleagrahara N (2018) Current concepts of neurodegenerative mechanisms in Alzheimer’s disease. Biomed Res Int 2018:3740461. https://doi.org/10.1155/2018/3740461
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944. https://doi.org/10.1212/wnl.34.7.939
Mietelska-Porowska A, Wasik U, Goras M, Filipek A, Niewiadomska G (2014) Tau protein modifications and interactions: their role in function and dysfunction. Int J Mol Sci 15:4671–4713. https://doi.org/10.3390/ijms15034671
Miller DB, O'Callaghan JP (2008) Do early-life insults contribute to the late-life development of Parkinson and Alzheimer diseases? Metab Clin Exp 57(Suppl 2):S44–S49. https://doi.org/10.1016/j.metabol.2008.07.011
Muresan V, Ladescu Muresan Z (2016) Shared molecular mechanisms in Alzheimer’s disease and amyotrophic lateral sclerosis: neurofilament-dependent transport of sAPP, FUS, TDP-43 and SOD1, with endoplasmic reticulum-like tubules. Neurodegener Dis 16:55–61. https://doi.org/10.1159/000439256
Muresan V, Villegas C, Ladescu Muresan Z (2014) Functional interaction between amyloid-beta precursor protein and peripherin neurofilaments: a shared pathway leading to Alzheimer’s disease and amyotrophic lateral sclerosis? Neurodegener Dis 13:122–125. https://doi.org/10.1159/000354238
Mushtaq G, H. Greig N, Anwar F, A. Zamzami M, Choudhry H, M. Shaik M, A. Tamargo I, A. Kamal M (2016) miRNAs as circulating biomarkers for Alzheimer’s disease and Parkinson’s disease. Med Chem (Shariqah (United Arab Emirates)) 12:217–225
Negoita SI, Sandesc D, Rogobete A, Dutu M, Bedreag O, Papurica M, Ercisli M, Popovici S, Dumache R, Sandesc M, Dinu A, Sas A, Serban D, Corneci D (2017) miRNAs expressions and interaction with biological systems in patients with Alzheimer’s disease. In: Using miRNAs as a diagnosis and prognosis biomarker clinical laboratory, vol 63, pp 1315–1321. https://doi.org/10.7754/Clin.Lab.2017.170327
Nogueira C, Erlmann P, Villeneuve J, Santos AJ, Martinez-Alonso E, Martinez-Menarguez JA, Malhotra V (2014) SLY1 and syntaxin 18 specify a distinct pathway for procollagen VII export from the endoplasmic reticulum eLife 3:e02784 doi:https://doi.org/10.7554/eLife.02784
O'Brien RJ, Wong PC (2011) Amyloid precursor protein processing and Alzheimer’s disease. Annu Rev Neurosci 34:185–204. https://doi.org/10.1146/annurev-neuro-061010-113613
Parihar MS, Hemnani T (2004) Alzheimer’s disease pathogenesis and therapeutic interventions. J Clin Neurosci 11:456–467. https://doi.org/10.1016/j.jocn.2003.12.007
Pietrzak M, Rempala G, Nelson PT, Zheng JJ, Hetman M (2011) Epigenetic silencing of nucleolar rRNA genes in Alzheimer’s disease. PLoS One 6:e22585. https://doi.org/10.1371/journal.pone.0022585
Qiu C, Kivipelto M, von Strauss E (2009) Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 11:111–128
Raghavan N, Tosto G (2017) Genetics of Alzheimer’s disease: the importance of polygenic and epistatic components. Curr Neurol Neurosci Rep 17:78. https://doi.org/10.1007/s11910-017-0787-1
Razgonova MP, Veselov V, Zakharenko A, Golokhvast K, Nosyrev A, Cravotto G, Tsatsakis A, Spandidos D (2019) Panax ginseng components and the pathogenesis of Alzheimer’s disease (review). Mol Med Rep. https://doi.org/10.3892/mmr.2019.9972
Roubroeks JAY, Smith RG, van den Hove DLA, Lunnon K (2017) Epigenetics and DNA methylomic profiling in Alzheimer’s disease and other neurodegenerative diseases. J Neurochem 143:158–170. https://doi.org/10.1111/jnc.14148
Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM (2016) Alzheimer’s disease. Lancet (London, England) 388:505–517. https://doi.org/10.1016/s0140-6736(15)01124-1
Sebastian-Serrano A, de Diego-Garcia L, Diaz-Hernandez M (2018) The neurotoxic role of extracellular tau protein. Int J Mol Sci 19. https://doi.org/10.3390/ijms19040998
Shao W, Peng D, Wang X (2017) Genetics of Alzheimer’s disease: from pathogenesis to clinical usage. J Clin Neurosci 45:1–8. https://doi.org/10.1016/j.jocn.2017.06.074
Sierra-Fonseca JA, Gosselink KL (2018) Tauopathy and neurodegeneration: a role for stress. Neurobiol Stress 9:105–112. https://doi.org/10.1016/j.ynstr.2018.08.009
Singh SK, Srivastav S, Yadav AK, Srikrishna S, Perry G (2016) Overview of Alzheimer’s disease and some therapeutic approaches targeting Aβ by using several synthetic and herbal compounds oxidative medicine and cellular longevity 2016:7361613–7361613 https://doi.org/10.1155/2016/7361613
Siokas V, Kardaras D, Aloizou AM, Asproudis I, Boboridis KG, Papageorgiou E, Hadjigeorgiou GM, Tsironi EE, Dardiotis E (2018) BDNF rs6265 (Val66Met) polymorphism as a risk factor for blepharospasm. NeuroMolecular Med 21:68–74. https://doi.org/10.1007/s12017-018-8519-5
Siokas V et al (2019) Lack of association of the rs11655081 ARSG gene with blepharospasm. J Mol Neurosci. https://doi.org/10.1007/s12031-018-1255-3
Skol AD, Scott LJ, Abecasis GR, Boehnke M (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38:209–213. https://doi.org/10.1038/ng1706
Sole X, Guino E, Valls J, Iniesta R, Moreno V (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics (Oxford, England) 22:1928–1929. https://doi.org/10.1093/bioinformatics/btl268
Theuns J, Verstraeten A, Sleegers K, Wauters E, Gijselinck I, Smolders S, Crosiers D, Corsmit E, Elinck E, Sharma M, Kruger R, Lesage S, Brice A, Chung SJ, Kim MJ, Kim YJ, Ross OA, Wszolek ZK, Rogaeva E, Xi Z, Lang AE, Klein C, Weissbach A, Mellick GD, Silburn PA, Hadjigeorgiou GM, Dardiotis E, Hattori N, Ogaki K, Tan EK, Zhao Y, Aasly J, Valente EM, Petrucci S, Annesi G, Quattrone A, Ferrarese C, Brighina L, Deutschlander A, Puschmann A, Nilsson C, Garraux G, LeDoux MS, Pfeiffer RF, Boczarska-Jedynak M, Opala G, Maraganore DM, Engelborghs S, de Deyn PP, Cras P, Cruts M, van Broeckhoven C, on behalf of the GEO-PD Consortium (2014) Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease. Neurology 83:1906–1913. https://doi.org/10.1212/wnl.0000000000001012
Tohgi H, Utsugisawa K, Nagane Y, Yoshimura M, Genda Y, Ukitsu M (1999a) Reduction with age in methylcytosine in the promoter region -224 approximately -101 of the amyloid precursor protein gene in autopsy human cortex brain research. Mol Brain Res 70:288–292
Tohgi H, Utsugisawa K, Nagane Y, Yoshimura M, Ukitsu M, Genda Y (1999b) The methylation status of cytosines in a tau gene promoter region alters with age to downregulate transcriptional activity in human cerebral cortex. Neurosci Lett 275:89–92
Tosun D, Landau S, Aisen PS, Petersen RC, Mintun M, Jagust W, Weiner MW (2017) Association between tau deposition and antecedent amyloid-beta accumulation rates in normal and early symptomatic individuals. Brain 140:1499–1512. https://doi.org/10.1093/brain/awx046
Van Cauwenberghe C, Van Broeckhoven C, Sleegers K (2016) The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med 18:421–430. https://doi.org/10.1038/gim.2015.117
Wang SC, Oelze B, Schumacher A (2008) Age-specific epigenetic drift in late-onset Alzheimer’s disease. PLoS One 3:e2698. https://doi.org/10.1371/journal.pone.0002698
Wang J, Yu JT, Tan MS, Jiang T, Tan L (2013) Epigenetic mechanisms in Alzheimer’s disease: implications for pathogenesis and therapy. Ageing Res Rev 12:1024–1041. https://doi.org/10.1016/j.arr.2013.05.003
Xie B, Liu Z, Liu W, Jiang L, Zhang R, Cui D, Zhang Q, Xu S (2017) DNA methylation and tag SNPs of the BDNF gene in conversion of amnestic mild cognitive impairment into Alzheimer’s disease: a cross-sectional cohort study. J Alzheimer's Dis 58:263–274. https://doi.org/10.3233/jad-170007
Yamaguchi T, Dulubova I, Min SW, Chen X, Rizo J, Sudhof TC (2002) Sly1 binds to Golgi and ER syntaxins via a conserved N-terminal peptide motif. Dev Cell 2:295–305
Zaganas I, Kapetanaki S, Mastorodemos V, Kanavouras K, Colosio C, Wilks MF, Tsatsakis AM (2013) Linking pesticide exposure and dementia: what is the evidence? Toxicology 307:3–11. https://doi.org/10.1016/j.tox.2013.02.002
Zhou XW, Gustafsson JA, Tanila H, Bjorkdahl C, Liu R, Winblad B, Pei JJ (2008) Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A. Neurobiol Dis 31:386–394. https://doi.org/10.1016/j.nbd.2008.05.013
Funding
This study was supported in part by a research grant from the Research Committee of the University of Thessaly, Greece (code 5287).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Stamati, P., Siokas, V., Aloizou, AM. et al. Does SCFD1 rs10139154 Polymorphism Decrease Alzheimer’s Disease Risk?. J Mol Neurosci 69, 343–350 (2019). https://doi.org/10.1007/s12031-019-01363-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-019-01363-3